News Focus
News Focus
icon url

sukus

05/03/21 11:53 PM

#374306 RE: sentiment_stocks #374271

So nice.
icon url

Nick119

05/04/21 12:09 AM

#374309 RE: sentiment_stocks #374271

Sentiment if you're actually looking for evidence of Linda Liau confirming 25% alive after 3 years, it's mentioned in her 2019 Grand Tour presentation. The same presentation where she talks about the amplification effects of adding PD-1 inhibitors to the mix results in increased tumor regression.

I can grab the link and timestamp tomorrow for your evidence/rebuttal arsenal :)
icon url

MI Dendream

05/04/21 7:06 AM

#374332 RE: sentiment_stocks #374271

A must read rebuttal of the nonsense that has appeared these last few days of short desperation.

BTW the future predictions of survival from 2017 and 2018, recall if you make it to 36 months, then you have a median survival of xxx, allows you to plot future KM values with a strong degree of certainty. The 5 year data point is around 17-20% of the combined groups which only drops to about 15% at 7.5 years. Combined folks, so 25% survival for the treated at 5 years is quite likely. These trial people were not young so between 5-7.5 years could just be age related stuff.

Thanks to exwannabe for making me think so hard about KM predictability many moons ago. He posted much critique when I used the lazy approach which was wrong, but shut up when I posted the right methods.
icon url

CherryTree1

05/04/21 7:52 AM

#374342 RE: sentiment_stocks #374271

Senti when you say:

we agree that we don’t have any criteria to compare that small sample to the DCVax patients other than some of them were methylated and some were not (we don’t even know the numbers on that) and that they all had GBM.

We do know the numbers from the still blinded journal article:
First results on survival from a large Phase 3 clinical trial of an autologous dendritic cell vaccine in newly diagnosed glioblastoma
https://translational-medicine.biomedcentral.com/articles/10.1186/s12967-018-1507-6

The MGMT gene promoter was methylated in 39.6% of patients (n = 131) and unmethylated in 48.9% (n = 162)


If that is what you mean when you say we don't know the numbers.


icon url

learningcurve2020

05/04/21 8:38 AM

#374363 RE: sentiment_stocks #374271

And somewhere in that 25% are likely patients who went on to other treatments like Optune's cap. Something else we've been kept in the dark on.